Prognostic features in patients with stage T1 breast carcinoma and a 0.5-cm or less lymph node metastasis: Significance of lymph node hilar tissue invasion

American Journal of Clinical Pathology

Volumn 111, Issue 1, 1999, Pages 21-28

  Goldstein, Neal S ^a   Mani, Anju ^a   Vicini, Frank ^a   Ingold, John ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Breast; Hilar tissue invasion; Invasive ductal adenocarcinoma; Micrometastases

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; CANCER GRADING; CANCER INVASION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0032926126     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/111.1.21     Document Type: Article

References (42)

1. Harrington SW. Carcinoma of the breast: surgical treatment and results. JAMA. 1929;92:208-213.
2. Truscott BM. Carcinoma of the breast: an analysis of the symptoms, factors affecting prognosis, results of treatment and recurrences in 1211 cases treated at Middlesex Hospital. Br J Cancer. 1947;1:129-142.
3. Saphir O, Amromin GD. Obscure axillary lymph node metastasis in carcinoma of the breast. Cancer. 1948;1:238-241.
4. Cady B, Sears HF. Usefulness and technique of axillary dissection in primary breast cancer. J Clin Oncol. 1986;4:623-624.
5. Neville AM. Are breast cancer axillary node micrometastases worth detecting. J Pathol. 1990;161:283-284.
6. Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer. 1994;73:505-508.
7. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer. 1994;73:664-667.
8. Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer: invasion, size, and nodal status involvement dramatically decreasing as a result of mammographic detection. Arch Surg. 1996;131:301-308.
9. Greco M, Agresti R, Raselli R, et al. Axillary dissection can be avoided in selected breast cancer patients: analysis of 401 cases. Anticancer Res. 1996;16:3913-5918.
10. McGee JM, Youmans R, Clingan F, et al. The value of axillary dissection in T1a breast cancer. Am J Surg. 1996;172:501-505.
11. White RE, Vezeridis MP, Konstadoulakis M, et al. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg. 1996;183:575-582.
12. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer. 1997;79:1918-1922.
13. Cady B. Use of primary breast carcinoma characteristics to predict lymph node metastases. Cancer. 1997;79:1856-1861.
14. Chontos AJ, Maher DP, Ratzer ER, et al. Axillary lymph node-dissection: is it required in T1a breast cancer? J Am Coll Surg. 1997;184:493-498.
15. Copeland EM III. Is axillary dissection necessary for T1 carcinoma of the breast? J Am Coll Surg. 1997;184:397-398.
16. Haffty BG, Ward B, Pathare P, et al. Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol. 1997;15:691-700.
17. Mustafa IA, Cole B, Wanebo HJ, et al. The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg. 1997;132:384-391.
18. Pandelidis SM, Peters KL, Walusimbi MS, et al. The role of axillary dissection in mammographically detected carcinoma. J Am Coll Surg. 1997;184:341-345.
19. Silverstein MJ, Barth A. Use of primary breast carcinoma characteristics to predict lymph node metastases-reply. Cancer. 1997;79:1862-1864.
20. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymph-adenectomy in breast cancer. J Clin Oncol. 1997;15:2345-2350.
21. Hartveit F. Tumour cells and the axillary nodes in breast cancer. Invest Cell Pathol. 1979;2:123-129.
22. Hartveit F. Paranodal vascular spread in breast cancer with axillary node involvement. J Pathol. 1979;127:111-114.
23. Hartveit F, Stoa KF, Tangen M. Early recurrence in breast cancer with efferent vascular invasion: a preliminary report. Invest Cell Pathol. 1980;3:141-145.
24. Hartveit F, Thoresen S, Thorsen T, et al. Histologic grade and efferent vascular invasion in human breast carcinoma. Br J Cancer. 1981;44:81-84.
25. Hartveit F, Samsonsen G, Tangen M, et al. Routine histological investigation of the axillary nodes in breast cancer. Clin Oncol. 1982;8:121-126.
26. Hartveit F, Skjœrven R, Mœhle BO. Prognosis in breast cancer patients with tumour cells in the efferent vessels of their axillary nodes. J Pathol. 1985;139:379-382.
27. Hartveit F, Mœhle BO, Halvorsen JF, et al. On the progressive nature of tumor growth in the axillary nodes in breast cancer. Oncology. 1983;40:309-314.
28. Hartveit F. The routine histological investigation of axillary lymph nodes for metastatic breast cancer. J Pathol. 1984;143:187-191.
29. Hartveit F. Paranodal tumor in breast cancer: extranodal extension versus vascular spread. J Pathol. 1984;144:253-256.
30. Hartveit F. Axillary metastasis in breast cancer: when, how, and why? Semin Surg Oncol. 1989;5:126-136.
31. Hartveit F, Lilleng PK. Breast cancer: two micrometastatic variants in the axilla that differ in prognosis. Histopathology. 1996;28:241-246.
32. Mœhle BO, Skjœrven R, Hartveit F. Efferent vascular invasion and the mean nuclear area of axillary nodal tumour cells in breast cancer. Diagn Histopathol. 1982;5:297-300.
33. Fisher ER, Gregorio RM, Redmond C, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4), III: the significance of extranodal extension of axillary metastases. Am J Clin Pathol. 1976;65:439-444.
34. Hultborn KA, Tornberg BO. Mammary carcinoma: the biologic character of mammary carcinoma studied in 517 cases by a new form of malignancy grading. Acta Radiol. 1960;196(suppl):1-143.
35. Elston CW, Ellis IO. Pathologic prognostic factors in breast cancer, I: the value of histological grade in breast cancer: experience from a large study with long term follow-up. Histopathology. 1991;19:403-410.
36. Rosen PP. Invasive duct carcinoma and morphological prognostic markers. In: Rosen PP, ed. Breast Pathology. New York, NY: Lippincott-Raven; 1997:275-293.
37. Toker C. Some observations on the deposition of metastatic carcinoma within cervical lymph nodes. Cancer. 1963;16: 364-374.
38. Van der Vali P, Meijer CJLM. Reactive lymph nodes. In: Sternberg SS, ed. Histology for Pathologists. New York, NY: Raven Press; 1992:233-252.
39. Dowlatshahi K, Fan M, Snider HC, et al. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. 1997;80:1188-1197.
40. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet. 1990;335:1565-1568.
41. Mambo NC, Gallager HS. Carcinoma of the breast: the prognostic significance of extranodal extension of axillary disease. Cancer. 1977;39:2280-2285.
42. Donegan WL, Stine SB, Samter TG. Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer. 1993;72:778-782.